The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Avent competitive analysis

Loading summary...

Latest oppositions filed by Avent

Explore patent oppositions filed by Avent against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3668568
Dosage Measurement Module On Injection PenELI LILLYMar 7, 2025
EP4017557
Methods And Apparatus For Aspects Of A Dose Detection SystemELI LILLYNov 4, 2024
EP3706841
Needle Shield Remover And A Medicament Delivery Device Comprising The Needle Shield RemoverSHL MEDICALAug 22, 2024
EP3184138
Needle Cover AssemblySHL GROUPJan 12, 2024
EP3666797
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENNov 10, 2023
EP3740265
A Medicament Delivery Device With A Removable Cap And Locking Member For Preventing Accidental ActiviationCONSORT MEDICALAug 16, 2023
EP3359229
Injector Comprising A Destructible Electric Circuit As A Result Of UseTECPHARMA LICENSINGFeb 16, 2023
EP3071262
Rotary Sensor Assembly With Space Efficient DesignNOVO NORDISKDec 22, 2020
EP3265152
Data Acquisiton Means, Especially For A Pen-Type Drug Delivery DevicesBEREYOct 22, 2020
EP2296728
Administration Device Having A Button With Touch SensorF HOFFMANN LA ROCHEJul 30, 2020

Latest patents of Avent opposed by its competitors

Explore Avent's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2928517
Aug 27, 2025Suction Cleaning Devices, Systems And Methods1
EP3151898
Mar 24, 2021Cleaning Devices, Systems And Methods1
EP2493466
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
EP2328503
Mar 25, 2020Thin, Smooth Nitrile Rubber Gloves1
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer10
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Latest PTAB cases involving Avent

Discover the latest PTAB cases involving Avent, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Avent

IPR2023-01045Jun 30, 2023NOVARTIS GENE THERAPIESAVENTISTerminated-Settled
IPR2019-00136Oct 31, 2018NEPTUNE GENERICSAVENTIS PHARMAInstitution Denied
IPR2016-00712Mar 15, 2016MYLAN LABORATORIESAVENTIS PHARMAFinal Written Decision
IPR2016-00627Feb 17, 2016MYLAN LABORATORIESAVENTIS PHARMAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Avent with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOFI AVENTIS DEUTSCHLAND1630 - 24
MYLAN PHARMACEUTICALS - - 94 -
PFIZER51944312
YPSOMED1814 - -